Immunisation and vaccines

Vaccination protects people against serious and life-threatening infectious diseases, such as influenza (flu), diphtheria, tetanus, pertussis (whooping cough), measles, mumps, rubella (German measles), meningococcal disease, invasive pneumococcal disease and polio.

Each year, vaccination stops 2.7 million people worldwide from getting measles, one million from getting pertussis and two million babies from getting tetanus.

In the past, many people died of diseases that can now be prevented through vaccination. People also suffered more commonly from disease-related complications, such as blindness due to measles and babies born with deafness, cataracts or learning disabilities due to their mothers getting rubella in pregnancy. Polio - as many people born before the 60's will remember - used to be a major cause of death, paralysis and lifelong disabilities in Europe and other regions.

Latest outputs

Publication

Communicable disease threats report, 29 August - 4 September, week 35

Publication -

News

ECDC awards 77 M€ to strengthen EU/EEA Member States’ capacities to detect and identify SARS-CoV-2 variants

News story -

News

ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines

Press release -

Publication

Interim public health considerations for the provision of additional COVID-19 vaccine doses

Publication -

Publication

Communicable disease threats report, 22-28 August, week 34

Publication -

Data

Combined indicator: 14-day notification rate, testing rate and test positivity, updated 9 September 2021, weeks 34-35

Map -

Data

Combined indicator: 14-day notification rate, testing rate and test positivity, updated 9 September 2021 (colour-blind friendly), weeks 34-35

Map -

Data

14-day case notification rate per 100 000 inhabitants, updated 9 September 2021, weeks 34-35

Map -

Data

Testing rates per 100 000 inhabitants, updated 9 September 2021, week 35

Map -

Data

Combined indicator: 14-day notification rate, testing rate and test positivity, updated 9 September 2021 (colour-blind friendly), weeks 34-35

Map -

Data

Infographic: Considerations for vaccinating adolescents against COVID-19

Infographic -

Data

Video on COVID-19 vaccination in the EU/EEA and the UK

Video -

Data

Video on vaccination: Effective worldwide vaccination campaigns

Video -

Data

Video on vaccination: Fighting tetanus

Video -

Data

Video on vaccination: Fighting measles

Video -

Peer-Reviewed Publication

To what extent does evidence support decision making during infectious disease outbreaks? A scoping literature review

Aug 2020

Peer-Reviewed Publication

Natural disasters and infectious disease in Europe: A literature review to identify cascading risk pathways

Jun 2020

Peer-Reviewed Publication

Human papillomavirus vaccination coverage, policies, and practical implementation across Europe

Feb 2020

Peer-Reviewed Publication

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)

Dec 2019

Peer-Reviewed Publication

Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort

Nov 2019

Vaccine-preventable diseases

Disease / public health area

Hepatitis B

Disease / public health area

Human papillomavirus

Disease / public health area

Invasive Haemophilus influenzae disease

Disease / public health area

Invasive pneumococcal disease

Disease / public health area

Japanese encephalitis

Disease networks

EUVAC.Net

European Invasive Bacterial Disease Surveillance Network (EU-IBD)

European Diphtheria Surveillance Network (EDSN)